MedPath
NMPA Approval

Ceftolozane Sulfate and Tazobactam Sodium for Injection

国药准字HJ20250016

February 8, 2025

Drug Information

注射用头孢洛生他唑巴坦钠

注射剂

1.5g(C₂₃H₃₀N₁₂O₈S₂ 1.0g与C₁₀H₁₂N₄O₅S 0.5g)

化学药品

February 8, 2025

February 7, 2030

Company Information

Applicant Company

Waarderweg 39, 2031 BN Haarlem, The Netherlands

Manufacturing Company

Steri-Pharma, LLC

429 S. West Street Syracuse, NY 13202, U.S.A.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用头孢洛生他唑巴坦钠 - NMPA 批准文号 | MedPath